{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:42:35Z","timestamp":1791319355884,"version":"4.3.1"},"reference-count":34,"publisher":"BMJ","issue":"9","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2013,10,1]]},"published-print":{"date-parts":[[2014,9]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Osteoporosis and fractures are frequently encountered in patients with Crohn's disease. In order to prevent fractures, treatment with bone protecting drugs appears warranted early in the course of bone disease when bone loss is not yet prominent. We therefore aimed to demonstrate a beneficial effect on bone density of the bisphosphonate risedronate in osteopenic Crohn's disease patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This double-blind, placebo-controlled randomised trial of risedronate with calcium and vitamin D supplementation was performed in osteopenic Crohn's disease patients. Patients were treated for 2\u2005years with follow-up after 3 and after every 6\u2005months. Disease characteristics and activity and bone turnover markers were assessed at all visits; dual x-ray absorptiometry was performed at baseline, 12 and 24\u2005months; radiographs of the spine at baseline and 24\u2005months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 132 consenting patients, 131 were randomised (67 placebo and 64 risedronate). Patient characteristics were similar in both groups, although the risedronate group was slightly heavier (body mass index 24.3 vs 23.0\u2005kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      ). Bone mineral density at lumbar spine increased 0.04\u2005g\/cm\n                      <jats:sup>2<\/jats:sup>\n                      on average in the risedronate group versus 0.01\u2005g\/cm\n                      <jats:sup>2<\/jats:sup>\n                      in the placebo group (p=0.007). The mean increase in total hip bone mineral density was 0.03 versus 0.01\u2005g\/cm\n                      <jats:sup>2<\/jats:sup>\n                      , respectively (p=0.071). Fracture prevalence and incidence were similar. Change of T-scores and concentrations of bone turnover markers were consistent with a beneficial effect of risedronate when compared with placebo. The effect of risedronate was primarily demonstrated in the first 12\u2005months of treatment. No serious unexpected suspected adverse events were observed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A 24-month treatment course with risedronate 35\u2005mg once weekly, concomitant with calcium and vitamin D supplementation, in osteopenic Crohn's disease patients improved bone density at lumbar spine.<\/jats:p>\n                    <jats:p>NTR 163 Dutch Trial Register.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2013-305523","type":"journal-article","created":{"date-parts":[[2013,10,21]],"date-time":"2013-10-21T22:29:23Z","timestamp":1382394563000},"page":"1424-1430","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":27,"title":["Treatment of bone loss in osteopenic patients with Crohn's disease: a double-blind, randomised trial of oral risedronate 35\u2005mg once weekly or placebo, concomitant with calcium and vitamin D supplementation"],"prefix":"10.1136","volume":"63","author":[{"given":"Ad A","family":"van Bodegraven","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, VU University Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Bravenboer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Endocrine Section, MOVE Research Institute, VU University Medical Center, Amsterdam, The Netherlands"},{"name":"Department of Clinical Chemistry, MOVE Research Institute, VU University Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit I","family":"Witte","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Dijkstra","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University Medical Center Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C Janneke","family":"van der Woude","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter C M","family":"Stokkers","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, St Lucas Andreas Hospital, Amsterdam, The Netherlands"},{"name":"Department of Gastroenterology, Academic Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice G","family":"Russel","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Medical Spectrum Twente, Enschede, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas","family":"Oldenburg","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University Medical Center Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke","family":"Pierik","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Maastricht University Medical Center, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan C","family":"Roos","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and Radiology, VU University Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruud A","family":"van Hogezand","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent K","family":"Dik","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, VU University Medical Center, Amsterdam, The Netherlands"},{"name":"Department of Gastroenterology, University Medical Center Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela E","family":"Oostlander","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Endocrine Section, MOVE Research Institute, VU University Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Coen","family":"Netelenbos","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Endocrine Section, MOVE Research Institute, VU University Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lex","family":"van de Langerijt","sequence":"additional","affiliation":[{"name":"Sanofi-Aventis, Gouda, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel W","family":"Hommes","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Academic Medical Center, Amsterdam, The Netherlands"},{"name":"Department of Gastroenterology, Leiden University Medical Center, Leiden, The Netherlands"},{"name":"Department of Gastroenterology, UCLA Health System, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Lips","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Endocrine Section, MOVE Research Institute, VU University Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2013,10,21]]},"reference":[{"key":"2025112111052358000_63.9.1424.1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-133-10-200011210-00012"},{"key":"2025112111052358000_63.9.1424.2","doi-asserted-by":"publisher","DOI":"10.1080\/00365520310007873"},{"key":"2025112111052358000_63.9.1424.3","doi-asserted-by":"publisher","DOI":"10.1136\/gut.51.5.654"},{"key":"2025112111052358000_63.9.1424.4","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3669"},{"key":"2025112111052358000_63.9.1424.5","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200308000-00004"},{"key":"2025112111052358000_63.9.1424.6","unstructured":"Schoon EJ van Nunen AB Wouters RS . Osteopenia and osteoporosis in Crohn's disease: prevalence in a Dutch population-based cohort. Scand J Gastroenterol Suppl 2000;232:43\u20137."},{"key":"2025112111052358000_63.9.1424.7","doi-asserted-by":"publisher","DOI":"10.1136\/gut.46.2.176"},{"key":"2025112111052358000_63.9.1424.8","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2003.09.027"},{"key":"2025112111052358000_63.9.1424.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2007.02.024"},{"key":"2025112111052358000_63.9.1424.10","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00496.2010"},{"key":"2025112111052358000_63.9.1424.11","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-005-0016-7"},{"key":"2025112111052358000_63.9.1424.12","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e3283200032"},{"key":"2025112111052358000_63.9.1424.13","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1053\/j.gastro.2010.09.007","article-title":"Histomorphometric analysis reveals reduced bone mass and bone formation in patients with quiescent Crohn's disease","volume":"140","author":"Oostlander","year":"2010","journal-title":"Gastroenterology"},{"key":"2025112111052358000_63.9.1424.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08761-5"},{"key":"2025112111052358000_63.9.1424.15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.6.785"},{"key":"2025112111052358000_63.9.1424.16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1742-1241.2008.01911.x","article-title":"Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club","volume":"63","author":"Bergmann","year":"2009","journal-title":"Int J Clin Pract"},{"key":"2025112111052358000_63.9.1424.17","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01448.x"},{"key":"2025112111052358000_63.9.1424.18","doi-asserted-by":"publisher","DOI":"10.1080\/00365520500206467"},{"key":"2025112111052358000_63.9.1424.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2007.05.016"},{"key":"2025112111052358000_63.9.1424.20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2003.01794.x"},{"key":"2025112111052358000_63.9.1424.21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-200X.2010.03174.x"},{"key":"2025112111052358000_63.9.1424.22","first-page":"141","article-title":"Intravenous ibandronate or sodium-fluoride\u2014a 3.5 years study on bone density and fractures in Crohn's disease patients with osteoporosis","volume":"20","author":"Klaus","year":"2011","journal-title":"J Gastrointestin Liver Dis"},{"key":"2025112111052358000_63.9.1424.23","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.59"},{"key":"2025112111052358000_63.9.1424.24","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2000.16518"},{"key":"2025112111052358000_63.9.1424.25","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-005-1927-z"},{"key":"2025112111052358000_63.9.1424.26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00372.x"},{"key":"2025112111052358000_63.9.1424.27","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.48.2005"},{"key":"2025112111052358000_63.9.1424.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2012.01.004"},{"key":"2025112111052358000_63.9.1424.29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030897"},{"key":"2025112111052358000_63.9.1424.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2012.06.003"},{"key":"2025112111052358000_63.9.1424.31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04667.x"},{"key":"2025112111052358000_63.9.1424.32","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.24119"},{"key":"2025112111052358000_63.9.1424.33","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.23352"},{"key":"2025112111052358000_63.9.1424.34","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.12110462"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2013-305523","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:05:37Z","timestamp":1763751937000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2013-305523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,21]]},"references-count":34,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2014,8,3]]},"published-print":{"date-parts":[[2014,9]]}},"alternative-id":["10.1136\/gutjnl-2013-305523"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2013-305523","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718151421.793498952","asserted-by":"object"}]},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,21]]}}}